Effect of denosumab on the incidence of fractures and mortality in patients undergoing hemodialysis: A retrospective cohort study
Denosumab may reduce all-cause mortality in patients undergoing hemodialysis, particularly in those with cardiovascular complications. This finding offers a promising direction for osteoporosis treatment in patients undergoing hemodialysis.
Authors
- Takashi Yokoo (ORCID: https://orcid.org/0000-0003-1838-7998)
- Ichiro Ohkido (ORCID: https://orcid.org/0000-0003-3905-9395)
- Akio Nakashima (ORCID: https://orcid.org/0000-0002-3730-0301)
- Kazuhiko Kato (ORCID: https://orcid.org/0000-0001-9197-9434)
- Tatsuhiro Yaginuma
- Arisa Kobayashi
Institutions
- Jikei University School of Medicine (JP)
- Kyoto University (JP)
- Nishijin Hospital (JP)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1371/journal.pone.0309657
- Citations
- 5
- Primary Topic
- Bone and Joint Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.39